Race Oncology Ltd
Quick facts
Marketed products
- Decitabine and cedazuridine · Oncology
Decitabine inhibits DNA methyltransferase to reactivate silenced tumor suppressor genes, while cedazuridine protects decitabine from deamination, allowing oral administration.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: